Skip to main content
Log in

Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer

  • Original Article
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objective: The purpose of the study is to evaluate whether surgery followed by radiotherapy in high-risk patients of early stage endometrial cancer can be replaced by formal surgical staging. Cancer-related survival and recurrence-free survival (RFS) were the endpoints of the analysis. Study design: One hundred and eighteen patients with endometrioid endometrial adenocarcinoma between 1996–2003 were reviewed. Patients with incomplete follow-up and extrauterine spread excluded, leaving 78 women in the final analysis. Low-risk patients (n=37) (Grade 1, myometrial infiltration <1/2 or Grade2, <1/3), treated by standard surgical procedure including total abdominal hysterectomy, bilateral salpingo-oophorectomy and peritoneal washing, while staging lymphadenectomy (n=24) or postoperative irradiation (n=17) was added in the high-risk group (Grade 1, >1/2 or Grade 2, >1/3 or Grade3). Results: The median age of patients was 65 years (range, 35–80 years) and the median follow-up 38 months (range, 9–98 months). The recurrence rate in low-risk patients was 2.7%, the cancer-related survival 97.5% and RFS 97%, while in the high-risk patients 12%, 93% and 88%, respectively. Comparing the therapeutic modalities (staging lymphadenectomy vs. postoperative irradiation) in the high-risk group the cancer-related survival and RFS was not differed (P=0.70, P=0.90, respectively). The high grade of the tumor was significantly correlated with RFS, while age, stage and myometrial infiltration were not. No moderate or severe complications developed after lymphadenectomy, while two moderate gastrointestinal complications occurred after adjuvant radiotherapy. Conclusion: According our results the low-risk patients of early stage endometrial adenocarcinoma had excellent survival with minimal intervention. The cancer-related survival and RFS in high-risk patients concerning the therapeutic modalities were comparable. Poor tumor differentiation was the most unfavorable prognostic factor related with RFS. Moderate complications developed only after postoperative radiotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aalders J, Abeler V, Kolstad P, Onsrud M (1980) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma clinical and histopathologic study of 540 patients. Obstet Gynecol 56:419–427

    PubMed  CAS  Google Scholar 

  2. Amant F, Moerman P, Neven P, Timmerman D, VanLimbergen E, Vergote I (2005) Endomatrial cancer. Lancet 366:491–505

    Article  PubMed  Google Scholar 

  3. Ayhan A, Taskiran C, Celik C et al (2002) Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage endometrial cancer? Gynecol Oncol 86:259–263

    Article  PubMed  Google Scholar 

  4. Ball HG (1996) Do we know the best therapy for the early stage endometrial cancer? Gynecol Oncol 60:173–175

    Article  PubMed  CAS  Google Scholar 

  5. Belinson JL, Lee KR, Badger GL, Pretorius RG, Jarre MA (1992) Clinical stage I adenocarcinoma of the endometrium, analysis of the reoccurrences and the potentional benefit of staging lymphadenectomy. Gynecol Oncol 44:17–23

    Article  PubMed  CAS  Google Scholar 

  6. Chassagne D, Sismondi P, Horiot JC et al (1993) A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol 26:183–202

    Article  Google Scholar 

  7. COSA-NZ-UK Endometrial Cancer Study Groups (1996) Pelvic lymphadenectomy in high-risk endometrial cancer. Int J Gynecol Cancer 6:102–107

    Article  Google Scholar 

  8. Cragun JM, Havrilesky LJ, Calingaert B et al (2005) Retrospective analysis of selective lymphadenectomy in apparent early stage endometrial cancer. J Clin Oncol 23:3653–3655

    Article  Google Scholar 

  9. Creasman WT (1990) New gynecology cancer staging. Obstet Gynecol 75:287–288

    PubMed  CAS  Google Scholar 

  10. Creasman WT, Morrow C, Bundy B, Homesley H, Graham J, Heller P (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecology Oncology Group study. Cancer 60:2035–2041

    Article  PubMed  CAS  Google Scholar 

  11. Creutzberg CL, Putten WLJ, Koper PCM et al for the PORTEC Study group (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage I endometrial Carcinoma multicenter randomized trial. Lancet 355:1404–1411

    Google Scholar 

  12. DiSaia PJ, Creasman WT, Boronow RC, Blessing JA (1985) Risk factors and recurrence patterns in stage I endometrial cancer. Am J Obstet Gynecol 151:1009–1015

    PubMed  CAS  Google Scholar 

  13. Gatta G, Lasota MB, Verfecchia A, the EUROCARE Working Group (1998) Survival of European women with gynaecological tumours during the period 1978–1989. Eur J Cancer 34:2218–2225

    Article  CAS  Google Scholar 

  14. Goudge C, Bernhard S, Cloven NG, Morris P (2004) The impact of complete surgical staging on adjuvant treatment decision in endometrial cancer. Gynecol Oncol 93:536–539

    Article  PubMed  Google Scholar 

  15. Homesley HD, Kadar N, Barrett RJ, Lentz SS (1992) Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma. Am J Obstet Gynecol 167:1225–1230

    PubMed  CAS  Google Scholar 

  16. Kaplan EL, Meier P (1958) Non parametric estimation for incomplete observations. J Am Stat Assoc 53:457–481

    Article  Google Scholar 

  17. Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecol Oncol 92:744–751

    Article  PubMed  Google Scholar 

  18. Kilgore LC, Patridge EE, Alvarez RD et al (1995) Adenocarcinoma of the endometrium. Survival comparison of patients with and without pelvic node sampling. Gynecol Oncol 56:29–33

    Article  PubMed  CAS  Google Scholar 

  19. Kitchener HC, Redman CW, Swart AMC, Amos CL (2005) ASTEC (Surgery component) A study in the treatment of endometrial cancer. A randomized trial of lymphadenectomy in the treatment of the endometrial cancer (Abstract book). Int J Gynecol Cancer 15:77

    Google Scholar 

  20. Larson DM, Broste SK, Krawist BR (1998) Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol 91:355–359

    Article  PubMed  CAS  Google Scholar 

  21. Larson DM, Connor GP, Broste SK, Krawist BR, Johnson KK (1996) Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 88:394–398

    Article  PubMed  CAS  Google Scholar 

  22. Lo KWK, Cheung TH, Yu MY, Yim SF, Chung TKH (2003) The value of pelvic and paraaortic lymphadenectomy in endometrial cancer to avoid unnecessary radiotherapy. Int J Gynecol Cancer 13: 863–869

    Article  PubMed  CAS  Google Scholar 

  23. Mariani A, Sebo TJ, Katzmann JA et al (2005) Endometrial cancer: can nodal status be predicted with curettage. Gynecol Oncol 96:594–600

    Article  PubMed  Google Scholar 

  24. Mohan DS, Samuels MA, Selim MA et al (1998) Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 70:165–171

    Article  PubMed  CAS  Google Scholar 

  25. Orr JW Jr, Holimon JL, Orr PF (1997) Stage I corpus cancer: is teletherapy necessary? Am J Obstet Gynecol 176:777–788

    Article  PubMed  Google Scholar 

  26. Potish RA, Dusenbury KE (1990) Enteric of postoperative pelvic external beam and brachytherapy for uterine cancer. Int J Oncol Biol Phys 18:1005–1010

    CAS  Google Scholar 

  27. Sabbatini PJ, Kaled MA. Barakat R (2000) Endometrial cancer. Handbook of gynecologic oncology.2nd edn. Martin Dunitz Publisher, London pp 283–296

    Google Scholar 

  28. Shachar IB, Pavelka J, Cohn D et al (2005) Surgical staging for patients presenting with grade I endometrial carcinoma. Obstet Gynecol 105:487–493

    Google Scholar 

  29. Straughn JM Jr, Huh WK, Orr JW Jr et al (2003) Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy. Gynecol Oncol 89:295–300

    Article  PubMed  Google Scholar 

  30. Trimble EL, Kosary C, Park RC (1998) Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 71:340–343

    Article  PubMed  CAS  Google Scholar 

  31. Wolfson AH, Sightier SE, Markoe AM et al (1992) The prognostic significance of surgical staging for carcinoma of endometrium. Gynecol Oncol 45:142–146

    Article  PubMed  CAS  Google Scholar 

  32. Zaino RJ, Kurman RJ, Diana KL, Morrow CP (1996) Pathologic model to predict outcome for women with endometrial adenocarcinoma. Cancer 77:1115–1121

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. Kalogiannidis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Papanikolaou, A., Kalogiannidis, I., Goutzioulis, M. et al. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer. Arch Gynecol Obstet 274, 91–96 (2006). https://doi.org/10.1007/s00404-006-0138-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-006-0138-y

Keywords

Navigation